logo
Mortgage and refinance interest rates today for July 14, 2025: Rates remain stagnant before inflation news

Mortgage and refinance interest rates today for July 14, 2025: Rates remain stagnant before inflation news

Yahooa day ago
Current mortgage interest rates have remained relatively unchanged. In fact, according to Zillow, the average 30-year fixed mortgage rate hasn't moved at all, sitting at 6.63%.
Mortgage rates may shift after the June Consumer Price Index (CPI) is released tomorrow. The CPI is a key measure of inflation, and the data could influence how the Federal Reserve plans to approach federal funds rate cuts for the rest of the year. If fed rate cuts look more likely, mortgage rates could decrease.
Dig deeper: How the Fed rate decision impacts mortgage rates
Here are the current mortgage rates, according to the latest Zillow data:
30-year fixed: 6.63%
20-year fixed: 6.22%
15-year fixed: 5.89%
5/1 ARM: 7.57%
7/1 ARM: 7.21%
30-year VA: 6.20%
15-year VA: 5.57%
5/1 VA: 6.51%
Remember, these are the national averages and rounded to the nearest hundredth.
These are today's mortgage refinance rates, according to the latest Zillow data:
30-year fixed: 6.68%
20-year fixed: 6.30%
15-year fixed: 6.06%
5/1 ARM: 7.59%
7/1 ARM: 7.12%
30-year VA: 6.33%
15-year VA: 6.06%
5/1 VA: 6.41%
Again, the numbers provided are national averages rounded to the nearest hundredth. Although it's not always the case, mortgage refinance rates tend to be a little higher than purchase rates.
Read more: The best mortgage refinance lenders right now
You can use the free Yahoo Finance mortgage calculator to play around with how different terms and rates will affect your monthly payment. Our calculator considers factors like property taxes and homeowners insurance when estimating your monthly mortgage payment. This gives you a better idea of your total monthly payment than if you just looked at mortgage principal and interest.
But if you want a quick, simple way to see how today's rates would impact your monthly mortgage payment, try out the calculator below:
Today's average 30-year mortgage rate is 6.63%. A 30-year term is the most popular type of mortgage because by spreading out your payments over 360 months, your monthly payment is relatively low.
If you had a $300,000 mortgage with a 30-year term and a 6.63% rate, your monthly payment toward the principal and interest would be about $1,922, and you'd pay $391,893 in interest over the life of your loan — on top of that original $300,000.
The average 15-year mortgage rate is 5.89% today. Several factors must be considered when deciding between a 15-year and 30-year mortgage.
A 15-year mortgage comes with a lower interest rate than a 30-year term. This is great in the long run because you'll pay off your loan 15 years sooner, and that's 15 fewer years for interest to compound.
However, your monthly payments will be higher because you're squeezing the same debt payoff into half the time.
If you get that same $300,000 mortgage but with a 15-year term and a 5.89% rate, your monthly payment would jump up to $2,514 — but you'd only pay $152,480 in interest over the years.
Dig deeper: How much house can I afford? Use our home affordability calculator.
With an adjustable-rate mortgage, your rate is locked in for a set period of time and then increases or decreases periodically. For example, with a 5/1 ARM, your rate stays the same for the first five years, then changes every year.
Adjustable rates usually start lower than fixed rates, but you run the risk that your rate goes up once the introductory rate-lock period is over. But an ARM could be a good fit if you plan to sell the home before your rate-lock period ends — that way, you pay a lower rate without worrying about it rising later.
Lately, ARM rates have occasionally been similar to or higher than fixed rates. Before dedicating yourself to a fixed or adjustable mortgage rate, be sure to shop around for the best lenders and rates. Some will offer more competitive adjustable rates than others.
Mortgage lenders typically give the lowest mortgage rates to people with higher down payments, excellent credit scores, and low debt-to-income ratios. So if you want a lower rate, try saving more, improving your credit score, or paying down some debt before you start shopping for homes.
You can also buy down your interest rate permanently by paying for discount points at closing. A temporary interest rate buydown (as mentioned early in the article) is also an option — for example, maybe you get a 6.5% rate with a 2-1 buydown. Your rate would start at 4.5% for year one, increase to 5.5% for year two, then settle in at 6.5% for the remainder of your term.
Just consider whether these buydowns are worth the extra money at closing. Ask yourself if you'll stay in the home long enough that the amount you save with a lower rate offsets the cost of buying down your rate before making your decision.
Here are interest rates for some of the most popular mortgage terms: According to Zillow data, the national average 30-year fixed rate is 6.63%, the 15-year fixed rate is 5.89%, and the 5/1 ARM rate is 7.57%.
A normal mortgage rate on a 30-year fixed loan is 6.63%. However, keep in mind that's the national average based on Zillow data. The average might be higher or lower depending on where you live in the U.S.
Mortgage rates probably won't drop significantly in 2025 — especially over the next several weeks while economists keep an eye on inflation, tariffs, and unrest in the Middle East.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Defi Tokens Are Soaring, Leaving Behind OG Coins Like LTC, BCH and XMR
Defi Tokens Are Soaring, Leaving Behind OG Coins Like LTC, BCH and XMR

Yahoo

time7 minutes ago

  • Yahoo

Defi Tokens Are Soaring, Leaving Behind OG Coins Like LTC, BCH and XMR

Bitcoin's surge to an all time high on Thursday evoked mixed reactions from altcoins, with some outperforming the largest cryptocurrency by market cap and others lagging behind. And that's split along industry lines. Tokens associated with decentralized finance (DeFi) and those from layer-2 blockchains are outperforming as investors transition to a risk-on approach. Others, such as tron (TRX), bitcoin cash (BCH), litecoin (LTC) and monero (XMR) are, in comparison, barely moving. Even solana (SOL), the darling of the previous drive to record highs, seems to be taking a back seat, rising just 3.9% while the likes of sei (SEI), ethena (ENA) and optimism (OP) are celebrating gains of as much as 28%. "Altcoins are leading the pack in this latest rally," Thomas Perfumo, Kraken's global economist, said in an email. A drop in bitcoin dominance is "reinforcing a broad-based rally with altcoins leading the charge." During the 2017 and 2021 runs to record highs, bitcoin dominance — a measure of BTC's share of the total crypto market —rose rapidly. On Thursday's rally, it fell to 63.5% from 64%, indicating a shift in emphasis toward the altcoin market Crypto markets are cyclical by nature. They run without interruption 24 hours a day against a backdrop of high volatility and low liquidity which can create an emotional trading environment. In previous cycles, altcoins often moved in unison, rising as bitcoin consolidated and dropping en masse when it rose or fell. This time, however, seems different, possibly due to the increased participation of institutions in the the industry. The rise in DeFi tokens can be attributed to increasing institutional interest in ether (ETH), which could pave the way for a search for yield with firms battling to secure the highest returns. The same can be said for layer-2 networks. As institutions run into the Ethereum blockchain's issues with latency and efficiency, they may consider networks like Arbitrum that allow liquidity to flow from decentralized exchanges to staking protocols at a fast rate. That network's ARB token is up 15% in the past 24 hours. Still, Petr Kozyakov, CEO at payments firm Mercuryo, said the rise in altcoins will be short-lived. "While altcoins are also in the green with Ethereum spiking past the $3,000 mark, the underlying 'orange pill' narrative remains steadfastly in place," he said. "Bitcoin's growing status as a store of value is one that more and more big players and institutions are simply unable to ignore." That's not a narrative that finds much support from Arthur Hayes, the BitMEX founder turned fund manager. 'Get ready for a monster alt season,' he told his followers on X after predicting that ETH would reach $10,000 this cycle. If Hayes' prediction holds true, bitcoin could face short-term difficulty as liquidity will inevitably flow into the altcoin market as traders attempt to capture speculative gains. This could also be a hammer blow to the old-school crypto coins, which all lack major catalysts for a boost. Sign in to access your portfolio

Revolutionizing Anesthesia Drug Management and Integrity
Revolutionizing Anesthesia Drug Management and Integrity

Medscape

time16 minutes ago

  • Medscape

Revolutionizing Anesthesia Drug Management and Integrity

Stocking and restocking anesthesia carts is tedious and meticulous — and it's highly regulated. Anesthesiologists have direct and extensive access to controlled drugs in a hospital setting, particularly potent opioids and sedatives, which makes these processes vulnerable to the potential of abuse. Within the anesthesia ecosystem, the doctor has a partner in the stocking and restocking process, and that's the hospital pharmacy staff. This team has so much reporting to do: logging which medications were used by which operating teams and on which patients — data that ultimately get reported to the Drug Enforcement Administration. Errors in any part of the dispensing, stocking, and securing process could result in waste, fines, medication errors, or worse. Hospitals have been on the search for help. Several companies have focused on what's called RAIN RFID. The technology uses passive ultrahigh frequency waves to essentially perform the function of Bluetooth or Wi-Fi for short-range device communication. It's available to hospitals to help with everything from patient tracking to equipment security and compliance. For anesthesia departments, the company Intelliguard created what it calls the Mira Ecosystem. It's built on RAIN RFID and monitors each vial of medication through its entire journey, filling clinical, compliance, and supply chain functions. Tray Setups and Refills Are Quick, Easy, and Traceable According to Intelliguard, about 90% of its systems are currently deployed to serve anesthesia departments. When vials of medication arrive at the pharmacy, a technician applies the Mira tag to each vial, and immediately, the system begins tracking each individual one. 'Our system reads each of the 96-bit unique IDs and then associates those unique IDs with the medication. So now each of those IDs is associated with rocuronium, for example, and the company that made it, the serial number, and the expiration and the lot number,' said Paul Elizondo, Intelliguard's chief innovation officer. 'From then on, when our system sees that 96-bit unique ID, it associates it with the medication in a database. It displays that on the screen, and we know exactly what that medication is now.' Paul Elizondo The system tracks each vial of medication throughout its journey at the hospital, giving pharmacy managers and hospital administrators instant, real-time visibility into where each vial is and when. In terms of daily pharmacy tasks, making up medication trays for anesthesiologists is made nearly foolproof, reducing medication errors. 'The hospitals using our system will place these RFID-tagged medications into the tray, then they will place that tray into our enclosure,' said Elizondo. 'In 6 seconds, we read every single tag in that tray, and we let them know if that formula, if what's in the tray, matches the formulary to which they're building right at that time.' The system can also check to ensure there are no expired or recalled medications in the tray. The real-time savings come, though, when the anesthesiologist returns the tray at the end of the day. Rady Children's Hospital in San Diego is using this system. Performance improvement pharmacist Ann McKinstry explained some of the ways that she's seen return on investment gains. 'Pinpointing the medication location has allowed for a more rapid response to expiry, recalls, and patient care events,' McKinstry said. 'Inpatient pharmacy inventory is tightened by offering a streamlined data review to analyze usage and reducing waste by tightening supply on hand. In addition, RFID tags allow accurate controlled substance reconciliation by monitoring usage, waste, and replenishment down to the minute.' Real-Time Tracking of Medication Location Saves a Life Knowing exactly where your medications are on a real-time basis isn't just important: It can be a matter of life and limb. For example, if a patient with a deadly North American pit viper bite is rolled into your emergency department, as happened at a Bartow, Florida hospital at 1 AM on May 4 — you'd definitely want to know if you have antivenom on hand. Bartow was out. They reached out to Prodigy Health, distributor of specialty pharmaceuticals that supplies medicines to hospitals on a consignment basis. Prodigy runs a 24-hour switchboard and uses RAIN to gain visibility into what is being dispensed by each hospital. The antivenom was quickly located at a hospital in Lutz, Florida, one that had a RAIN RFID cabinet. The request was made, the antivenom was transferred, and the day was saved. Ty Dishman Before this technology, 'This process was manual and time-consuming. Now, with reliable data integrating into our system every 6 seconds, we're able to provide immediate, confident answers to customer inquiries about medication availability and delivery timelines,' said Ty Dishman, CEO of Prodigy Health. 'Instead of saying, 'I think it's there — let me check and call you back,' we can act quickly and efficiently, ensuring life-saving medications are mobilized without delay.' The Competitive Landscape RFID systems are nothing new in the healthcare environment. They're commonly used to track medical equipment and inventory, as well as in staff badging systems. Its use in medication management is fairly recent. Terso Solutions offers a similar suite to the Mira Ecosystem, with the exception of Intelliguard's direct-to-operating room tray system; Avery Dennison Medical and Healthcare provides a wide range of pharmaceutical labeling options, and some options include RFID.

What You Need To Know Ahead of Tyson Foods' Earnings Release
What You Need To Know Ahead of Tyson Foods' Earnings Release

Yahoo

time21 minutes ago

  • Yahoo

What You Need To Know Ahead of Tyson Foods' Earnings Release

Valued at $19.3 billion by market cap, Springdale, Arkansas-based Tyson Foods, Inc. (TSN) operates as the biggest U.S. chicken company and produces, distributes, and markets chicken, beef, pork, as well as prepared foods. The farm products giant is expected to announce its third-quarter results before the markets open on Monday, Aug. 4. Ahead of the event, analysts expect Tyson Foods to deliver a profit of $0.79 per share, down 9.2% from $0.87 per share reported in the year-ago quarter. On the positive note, the company has a solid earnings surprise history and has surpassed the Street's bottom-line estimates in each of the past four quarters. Palantir Just Launched Warp Speed for Warships. Does That Make PLTR Stock a Buy? This Analyst Just Doubled His Price Target on AMD Stock How High Can Nvidia Stock Go as Jensen Huang Heads to China? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! For the full fiscal 2025, analysts expect TSN to report an EPS of $3.83, up a staggering 23.6% from $3.10 reported in fiscal 2024. In fiscal 2026, its earnings are expected to further grow 10.7% year-over-year to $4.24 per share. TSN stock prices have dropped 5.2% over the past 52 weeks, notably underperforming the S&P 500 Index's ($SPX) 11.6% gains and the Consumer Staples Select Sector SPDR Fund's (XLP) 4.4% uptick during the same time frame. Tyson Foods' stock prices plunged 7.8% following the release of its mixed Q2 results on May 5. Although the company reported hikes in product prices, its volumes remained under pressure. This led to its overall topline remaining flat year-over-year at $13.1 billion, missing the consensus estimates by 61 basis points. Meanwhile, its gross profits took a hit due to rising cost of sales, and its operating cash flows for the quarter dropped 28.1% year-over-year to $846 million. However, its adjusted EPS of $0.92 surpassed the consensus estimates by 8.2%. The stock maintains a consensus 'Moderate Buy' rating overall. Of the 10 analysts covering the TSN stock, opinions include three 'Strong Buys' and seven 'Holds.' Its mean price target of $64 indicates a 17.8% upside potential from current price levels. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store